April 24, 2024
EGC Wins 2024 Growth Accelerator Fund Competition
Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA), in recognition of the firm’s impactful contributions toward increasing equitable access to resources for entrepreneurs from underrepresented groups.
March 18, 2024
Senior Grants Expert Dr. Tiger Xie was Featured at NCATS Webinar
Dr. Xiaohu (Tiger) Xie, was a featured speaker at the National Center for Advancing Translational Science (NCATS) and Georgia Clinical & Translational Science Alliance (CTSA’s) Small Business Funding Webinar.
January 22, 2024
EGC CEO, Dr. Garland Participated in Women+ in Climate Tech Global Network Panel Discussion
Dr. Eva Garland joined Justina W. Gallegos, Deputy Director, White House Office of Science and Technology Policy; Maya Goodwin, Senior Advisor, Workforce and Economic Opportunity Policy, Department of Energy
January 7, 2024
EGC Sponsorsed RESI at JPM Conference in San Francisco
EGC sponsored the Redefining Early Stage Investments (RESI) Conference at the JP Morgan Conference in San Francisco.
September 26, 2023
EGC’s Dr. Heaney Presented at BioVenture Nexus in LA
The EGC Team attended the BioVenture Nexus conference in Los Angeles. BioVenture Nexus is the premier event for innovation and networking in the Synthetic Biology, Biotech Industry, Life Science, Food Tech, and AI in Biology.
August 18, 2023
EGC Receives Six-Time Inc. 5000 Recognition
Eva Garland Consulting, LLC (EGC) is excited once again to be named as one of the fastest growing privately owned companies in the United States by capturing a spot on the Inc. 5000 list for the sixth consecutive year.
August 9, 2023
EGC’s Leadership of NIH AAP Enters 5th Year
Eva Garland Consulting (EGC) is thrilled to extend our partnership with the National Institutes of Health (NIH) to support small businesses in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP).
June 22, 2023
EGC Presented at a NCATS Workshop on Non-Dilutive Funding
Dr. Xiaohu (Tiger) Xie, a Scientific Grants Expert from EGC, presented a talk titled “Application Tips & Resources to Help Secure SBIR & STTR Funding”, sponsored by the NIH's National Center for Advancing Translation Science (NCATS).
June 20, 2023
Dr. Garland Moderated Panel at National SBIR Conference
EGC CEO, Dr. Eva Garland, moderated a panel titled "Executing My Award" at the 2023 SBIR / STTR Spring Innovation Conference.
June 14, 2023
EGC Releases New SBIR Book
Eva Garland Consulting (EGC) is excited to announce the publication of the 4th edition of our Amazon best-selling book on the NIH SBIR/STTR program.
May 12, 2023
NIH and EGC Partnership Supports SBIR/STTR Applicants
EGC is excited to extend our partnership with the National Institutes of Health (NIH) to provide small businesses with FREE support in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP).
February 26, 2023
Press Release: EGC Leads National Initiative to Stop New Tax on Research
EGC is leading a collaborative national effort to raise awareness of a new tax law that requires capitalization of Research & Experimentation (R&E) expenses and detrimentally impacts companies conducting critical scientific work.
February 5, 2023
Three Triangle Life Science Execs Crack ‘Women in Business Awards’
Three outstanding life sciences leaders are among the 25 awardees of the Triangle Business Journal 2023 Women in Business Awards. Here they are.
February 1, 2023
2023 Non-Dilutive Funding Outlook
EGC has released our 2023 US Non-Dilutive Funding Outlook. Click here to view the report.
September 2, 2022
EGC Leads “Elevate Vermont”
EGC is pleased to assist technology startups and small businesses in Vermont in applying for federal SBIR/STTR grant money through a new state program called "Elevate Vermont".